Regeneron’s Libtayo approved as flexible dosing schedule in EU
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer
The funding will be for a GLP-1 receptor agonist clinical programme for weight loss
The companies focus on fibrosis and oncology, and novel treatments for respiratory conditions, respectively
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer
The new site will expand research capabilities across immunology, neuroscience and oncology
MAD World Summit takes place in London on 26 November at Convene, 155 Bishopsgate
Nov 5, 2026 | Thought Leadership
Continuous engagement depends on a steady stream of timely, compliant content
Read MoreNov 4, 2026 | Thought Leadership
When priority scientific questions are being answered, how visible, accurate and useful is our evidence?
Read MoreNov 3, 2026 | Thought Leadership
We need to make scientific information easier to find and support more evidence-based voices online
Read MoreNov 2, 2026 | Thought Leadership
Influence rarely happens in a single post. Trust is built through repeated, credible interactions over time
Read More
Nov 12, 2026 | Intelligence
What the expanded global talent route means for life sciences
Read MoreNov 11, 2026 | Intelligence
Websites and HCP portals are making real gains across Europe – but AI-mediated discovery is quietly resetting the standard for content that HCPs and machines can trust
Read MoreNov 10, 2026 | Intelligence
Three waves of innovation pharma leaders should watch
Read MoreNov 9, 2026 | Intelligence
Investment in rare disease biotechs has increased since the FDA’s Priority Review Voucher scheme was renewed
Read MoreNov 2, 2026 | Intelligence
Connecting with patients and HCPs through social media channels needs care and consistency
Read MoreOct 15, 2026 | Intelligence
Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms
Read More

November 16, 2026 | Nmblr|Biopharma commercialisation strategy, collaboration, competitive advantage
Align, a new toolkit designed to help biopharma teams execute commercialisation strategies with greater efficiency, agility and lasting impact, has been unveiled today. Part of …

November 10, 2026 | Medscape Education|Blood Cancer United, Caregiver Central Sponsor, Hematology Education, Light the Night
MERCER COUNTY, NJ — Recognizing that clinical excellence and patient experience are inseparable, Medscape Oncology served as the official Caregiver Central Sponsor in support of …

November 10, 2026 | Genesis Research Group|AI, HEOR, Market Access, RWE, evidence generation, evidence generation planning platform, evidence planning, evidence strategy, iegp, technology
Genesis Research Group (Genesis) launches Keystone, its modular platform for Integrated Evidence Generation Planning (IEGP), at ISPOR Europe 2026.
November 10, 2026 | Emotive—Powered by Petauri|
Acquisition strengthens Petauri’s medical communications collective, Petauri Advance, with expanded global scale and deep scientific, strategic, and creative expertise.

November 9, 2026 | Medscape Education|AASLD, Fatty Liver Alliance, Liver Health, MASH, Medscape Event, patient advocacy
“The view from the top is always better with the people who helped us get there.”
November 17, 2026 | KJT Group|Insights, metabolic care, real-world evidence
Metabolic medicine is changing faster than the evidence systems built to track it. New therapies for type 2 diabetes and obesity are reaching more patients, …
November 17, 2026 | KJT Group|
AI-moderated interviewing emerged as an extension of the shift to online qual accelerated by COVID. According to Greenbook’s GRIT tracking, COVID boosted online qual adoption …
November 17, 2026 | Amiculum|HTA, JCA, Market Access
By Craig Tallentire
November 9, 2026 | Amiculum|artificial intelligence, medical affairs
What does a high-value medical affairs organization look like in a world of constrained resources, increasingly capable artificial intelligence (AI) and easier access to scientific …
November 3, 2026 | Inizio|AI, Pharma, healthcare
AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI …
